Advanced Oncotherapy Share Discussion Threads

[waterloo01] 22/2/2018 13:03

Just shows the large hole with a digger down the bottom and loads of supports keeping the neighbouring properties from falling in!

[scottishfield] 22/2/2018 13:01

Mmm, not sure then I'm afraid

[waterloo01] 22/2/2018 12:58

nothing happens when I copy and try and paste into here?

[scottishfield] 22/2/2018 12:42

I thin if you right click on a picture, you can take it from there via the options waterlooO1; copy & paste etc

[paul_98] 17/2/2018 23:11

I hope the same. If it is all true and on target (as promised), then we are in for excellent money.

[daijavu] 16/2/2018 11:58

Against my better judgement, I've just topped up. however, I am mindful that AVO was at precisely this place two years ago.

According to the BoD, the development of LIGHT was on target to be completed before the end of 2016, they had been awarded contracts in China, signed in front of our PM, David Cameron and senior members of the Chinese Government, and had just raised a substantial amount of cash to bring everything to a conclusion.

You would never imagine any of that had happened. It has been erased from the record.

I only hope it is different this time.

[jayj4u] 16/2/2018 10:23

...........the Company has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of the GBP13,500,000 payable by Yantai Cipu for the subscription for 45,000,000 new ordinary shares of GBP0.25 each to be issued by the Company to Yantai Cipu (the "Subscription") at GBP0.30 per share (the "Subscription Price").

[paul_98] 16/2/2018 09:28

Selling? What? This is an incredible share price, in my humble opinion 100p plus very soon.

[jayj4u] 16/2/2018 09:03

I studied Physics at UCL and my favorite subject was atomic physics. I can tell you that the technology they are developing has massive implication. My professors were working at CERN and i think this company has hit the JACKPOT! I will be visiting my university next week and speaking to professors regarding this company and its technology.

[paul_98] 16/2/2018 08:37

It will. This will,IMO, not all be happening without massive inside knowledge of the progress. SO POSITIVE!!! Yes!

[daijavu] 16/2/2018 08:24

It is good news but I still remain cautious.

A lot depends on the technology being fully developed to the timeline promised by the BoD so that production can go ahead.

[jayj4u] 16/2/2018 07:34

THIS IS THE MOST IMPORTANT PART!!!!

Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant. The commitment of Yantai Cipu vis-à-vis the Distribution Agreement is unchanged, and the receipt of the GBP16,500,000 payment from Yantai Cipu relating to the commercial agreement with Yantai Cipu also announced on 7 December 2017 is not conditional on the completion of negotiations with the distribution company.

[jayj4u] 16/2/2018 07:16

RNS Number : 0737F

Advanced Oncotherapy PLC

16 February 2018

ADVANCED ONCOTHERAPY PLC

("Advanced Oncotherapy" or the "Company")

Completion of the Subscription Agreement

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement dated 7 December 2017 and following the passing of the resolution proposed for the vote of the Company' shareholders on 23 January 2018, the Company has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of the GBP13,500,000 payable by Yantai Cipu for the subscription for 45,000,000 new ordinary shares of GBP0.25 each to be issued by the Company to Yantai Cipu (the "Subscription") at GBP0.30 per share (the "Subscription Price").

As a consequence of the completion of the Subscription by Yantai Cipu, and as detailed in the circular dated 22 December 2017 (the "Circular"), the placing of 10,868,782 new ordinary shares with new and existing investors at the Subscription Price (the "Placing"), as well as the conversion of the loan made by Swedish Investors by way of issue of 13,697,697 new ordinary shares (the "Conversion"), have also been completed.

Application has been made for admission to trading on AIM ("Admission") of the 69,566,479 new ordinary shares deriving from the Subscription, the Placing and the Conversion and it is expected that Admission will occur on or around 22 February 2018. Following Admission, the total number of ordinary shares in issue will be 150,501,673 and Yantai Cipu will hold 29.90% of the enlarged issued share capital of the Company.

Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant. The commitment of Yantai Cipu vis-à-vis the Distribution Agreement is unchanged, and the receipt of the GBP16,500,000 payment from Yantai Cipu relating to the commercial agreement with Yantai Cipu also announced on 7 December 2017 is not conditional on the completion of negotiations with the distribution company. The receipt of funds in relation to the commercial agreement is subject to approval from the Government of the People's Republic of China for the transfer of monies to the United Kingdom.

Lancea LLP advised the Company on the Subscription and Distribution agreements made by Yantai Cipu.

For further information, please contact:

[paul_98] 14/2/2018 09:14

Very quiet chat forum! Any thoughts out there on this?

[paul_98] 09/2/2018 16:50

Solid end to this week. Considering world markets we can feel good here. GLA.

[paul_98] 09/2/2018 09:27

Good point. I would have hoped for some sort of update on this progress.

[makeamillion1] 09/2/2018 08:31

Hi Paul

I would hope monies will be received soon especially with Chinese New Year upon us the end of next week which will basically be then a 2 week shut down. I would be very surprised if it is not before this time.

[paul_98] 09/2/2018 07:42

Any thoughts?

[paul_98] 03/2/2018 07:11

Any indication of when the Chinese money will arrive?

[paul_98] 29/1/2018 07:21

Much further down the line now, tech, Harley Street, de-risked. I don't see it as the same at all. Some do obviously which is fine. Much, much better situation now. More solid in many ways. IMO.

[daijavu] 29/1/2018 00:54

Paul.

It was exactly the same before the share price tanked two years ago.

The money was secured, according to the BoD, the tech was on target even though it wasn't, directors were investing heavily, there was a huge market and AVO had even won multiple contracts in China which it went on to lose.

I am waiting to see if it really is different now.

[paul_98] 24/1/2018 10:16

Resolutions passed, money secured. Is awaiting arrival, tech on target, directors invested heavily, huge market yet people are selling?!

[baner] 24/1/2018 08:29

I am not sure the chinese money have landed in UK yet? Once they have - the shares should move on very nicely, no doubt.

[paul_98] 24/1/2018 08:01

So now they go ahead and have the funding transferred? Great! What a year ahead.